Skip to main content

Candriam S.C.A.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1537014 STRASSEN, N4

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$38,725,370
-$5,742,359 QoQ
Shares Held
72,121
-15.1% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#55
of 411 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. MDGL ranks #17 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,725,370 72,121
2026-03-31 $44,467,729 84,948
2025-12-31 $37,215,020 63,906
2025-09-30 $22,916,946 49,965
2025-06-30 $15,121,407 49,965
2025-03-31 $7,079,047 21,372
2024-03-31 $4,806,720 18,000
2023-12-31 $6,247,260 27,000
2023-09-30 $4,235,160 29,000
2023-06-30 $6,699,000 29,000
2021-03-31 $3,710,522 31,722
2020-12-31 $3,526,534 31,722
2020-09-30 $11,229,958 94,584
2020-06-30 $11,617,638 102,584
2020-03-31 $2,733,822 40,950